Literature DB >> 18360075

Correlation between clinical pathologic factors and activity of 5-FU-metabolizing enzymes in colorectal cancer.

Takeshi Yamada1, Noritake Tanaka, Kimiyoshi Yokoi, Tomoko Seya, Yoshikazu Kanazawa, Michihiro Koizumi, Yoshiharu Ohaki, Takashi Tajiri.   

Abstract

INTRODUCTION: Orotate phosphoribosyl transferase (OPRT), dihydropyrimidine dehydrogenase (DPD), and thymidylate synthase (TS) are initial key enzymes in the 5-fluorouracil (5-FU) metabolic pathway. The expression levels and activities of these three enzymes play important roles in the response of cancer patients to 5-FU-based chemotherapy.
PURPOSE: The purpose of this study was to investigate the relationship between the activities of 5-FU metabolic enzymes and clinicopathologic factors in colorectal cancer.
METHODS: We measured the activities of OPRT, DPD, and TS in colorectal cancer tissues. We also investigated the correlations between the activities of these three enzymes and clinicopathologic factors (histological type, depth of tumor invasion, extent of lymph node metastasis, Dukes' stage, lymphatic invasion, and vascular invasion). We examined 100 patients with surgically resected colorectal cancer.
RESULTS: Poorly differentiated adenocarcinoma showed significantly higher DPD activities than did moderately differentiated or well-differentiated adenocarcinoma. In patients with lymph-node metastasis, OPRT activity was significantly lower than in patients without lymph-node metastasis. No significant relation was found between TS activity and histological type, depth of tumor invasion, extent of lymph node metastasis, Dukes' stage, lymphatic invasion, or vascular invasion.
CONCLUSION: The response to 5-FU may be poor in patients with lymph-node metastasis, because of low OPRT activity, and in patients with poorly differentiated adenocarcinoma, because of high DPD activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360075     DOI: 10.1272/jnms.75.23

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  2 in total

1.  Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort study.

Authors:  Teppei Miyakawa; Hidetaka Kawamura; Michitaka Honda; Yoshinao Takano; Shunji Kinuta; Takahiro Kamiga; Shigeru Yamazaki; Atsushi Muto; Satoru Shiraso; Naoyuki Yamashita; Toshiyasu Iwao; Koji Kono; Shinichi Konno
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

2.  Tumor site- and stage-specific associations between allelic variants of glutathione S-transferase and DNA-repair genes and overall survival in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.

Authors:  Ching-Yu Lai; Ling-Ling Hsieh; Fung-Chang Sung; Reiping Tang; Chyi-Huey Bai; Fang-Yang Wu; Hung-Yi Chiou; Chih-Ching Yeh
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.